The findings add to previous research on similar outcomes between psoriasis and cardiovascular disease, using a Mendelian randomization study.
There is evidence for a causal link between psoriasis and cardiovascular disease (CVD), suggesting the importance of early monitoring of cardiovascular risk in patients with psoriasis, according to a study recently published in Frontiers in Immunology.
Although patients with psoriasis are known to have a higher risk for CVD, this study builds upon previous research by investigating a causal link between psoriasis and CVD.
“A large number of observational studies showed that patients with psoriasis have a higher risk of CVD, but most studies did not fully adjust for confounding factors, so it is not clear whether the risk of CVD is directly attributed to psoriasis,” wrote the authors.
They conducted a 2-sample Mendelian randomization to evaluate the potential causal relationship between psoriasis and CVD using genetic evidence. Genetic instruments from the genome-wide association study of European descent for psoriasis were used to investigate the relationship. Inverse variance-weighted Mendelian randomization analyses were used, in addition to a variety of other methods.
The analysis indicated that genetic susceptibility to psoriasis was associated with a higher risk of multiple CVDs. Psoriasis was associated with a higher risk of heart failure (odds ratio [OR], 1.04; 95% CI, 1.01-1.06; P = 2.72E-03), atrial fibrillation (OR, 1.04; 95% CI, 1.02-1.07; P = 3.27E04), myocardial infarction (OR, 1.07; 95% CI, 1.01-1.12; P = .01), valvular heart disease (OR, 1.001; 95% CI, 1.000-1.002; P = 1.85E-03), and large artery stroke (OR, 1.11; 95% CI, 1.05-1.18; P = 5.37E-04).
Notably, susceptibility to psoriasis was found to not be associated with a higher risk of ischemic stroke (OR, 1.03; 95% CI, 0.98-1.07; P = .27) or small vessel stroke (OR, 1.00; 95% CI, 0.95-1.07; P = .88).
The sensitivity analysis found weak evidence of horizontal diversity and heterogeneity, ensuring the stability of the results.
Overall, these findings provide evidence for a potential causal relationship between psoriasis and CVD.
The exact mechanism by which psoriasis increases the risk of CVD, if it increases the risk at all, has been debated in previous research. Studies on the relationship between psoriasis and CVD did not adjust for confounding factors, the authors of the present investigation noted, preventing the establishment of a causal relationship.
A strength of this study is that it explores this causal relationship between psoriasis and a series of CVDs. The authors assert that their results are unlikely to be influenced by confounders. Additionally, multiple analytical tools used produced consistent results, while the sensitivity analysis indicated the study results were reliable.
However, the study also faced limitations. The authors acknowledge that the OR value is relatively low, necessitating careful interpretation when generalizing results.
The researchers encourage more in-depth research on the relationship between psoriasis and CVD with a broader population beyond Europe. They also recommend early cardiovascular risk assessment and prevention in patients with psoriasis to facilitate the introduction of individual-specific treatments as soon as possible.
Reference
Gao N, Kong M, Li X, et al. The association between psoriasis and risk of cardiovascular disease: a Mendelian randomization analysis. Front Immunol. Published online June 29, 2022. doi:10.3389/fimmu.2022.918224
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More